PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Deliveryâ¢ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO Inte